Congratulations to the three Department of Pediatrics faculty members awarded the Pediatric Health Services Foundation (HSF) Clinical Program Development Grant this year. Listed below are the faculty ...

Organon & Co. (NYSE:OGN) is one of the 13 Cheap Healthcare Stocks with Huge Upside Potential. On July 2, Organon & Co. (NYSE:OGN) announced that its Phase 2 ELENA proof-of-concept study did not meet ...

ARPA-H, part of HHS, has earmarked up to $142 million for 10 research projects building the tools, data, and infrastructure needed to tackle treatment resistance.

With a new leadership team and fast-track designation from the FDA, Prescient Therapeutics is laser focused on development of ...

Oncolytics Biotech® Names New CEO To Accelerate Momentum In Immunotherapy Programs. Date. 2025-06-11 07:01:11. ... With a renewed focus and sharpened clinical development plan, ...

Serving the community, advancing knowledge The Institute for Community Mental Health (ICMH) at the University of Delaware stands as a pioneering initiative led by the clinical science faculty within ...

Organon will discontinue its OG-6219 clinical-development program, after the investigational candidate failed to meet its primary efficacy endpoint in treating endometriosis-related pain.

Mosaic Therapeutics In-Licenses Two Clinical-Stage Oncology Programs From Astex Pharmaceuticals for Development as Proprietary Combination Therapies Provided by Business Wire Apr 24, 2025 7:24am ...

Webcast and conference call to be held on Monday, June 30th at 4:30 pm ET, dial in information below NEWARK, CA / ACCESS Newswire / June 26, 2025 / Protagonist Therapeutics, Inc. (“Protagonist” or the ...

Northeastern State University’s School of Social Work has been awarded a transformative $2.3 million grant from the Health ...

Phase 1b study supports proof-of-concept in DOK7 congenital myasthenic syndromes Decision informed by favorable safety profile and consistent functional improvement over time across multiple efficacy ...

The company notes that the workforce reduction is expected to provide annual cash compensation cost savings of approximately $15 million and offsets additional expenses expected based on the ...